Skip to main content

Posts

Showing posts with the label pharmaceutical news

Featured Post

Market Daily Report: Bursa Malaysia Closes Higher On BNM’s OPR Decision, Wall Street Gains

KUALA LUMPUR, Nov 5 (Bernama) -- Bursa Malaysia closed higher, buoyed by Bank Negara Malaysia’s (BNM) decision to maintain the Overnight Policy Rate (OPR) at 2.75 per cent, alongside positive cues from Wall Street. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) rose 19.30 points, or 1.19 per cent, to 1,635.86 from Wednesday’s close of 1,616.56. The benchmark index opened 6.72 points higher at 1,623.28, and fluctuated between an intraday high of 1,642.44 and a low of 1,622.62 during the trading session. However, market breadth was negative, with losers outnumbering gainers 723 to 497, while 466 counters were unchanged, 1,075 untraded and 10 suspended. Turnover rose to 3.74 billion units valued at RM3.61 billion compared with yesterday’s 2.81 billion units valued at RM2.57 billion.

Novartis Restructures: 330 Jobs Affected as MorphoSys Sites Close

 Swiss pharmaceutical giant  Novartis  announced plans to wind up operations at  MorphoSys sites  in  Munich, Germany , and  Boston, USA , by the  end of 2025 , affecting approximately  330 jobs . Key Details Acquisition Context : Novartis acquired MorphoSys earlier this year and is restructuring as part of an  evaluation of its R&D setup . Impact on Employees : Affected employees, approximately  330 roles , were notified in  mid-November . Novartis has committed to supporting impacted individuals through the transition. Official Statement : "We have communicated our intention to exit the MorphoSys sites by end of 2025," said a Novartis spokesperson in a statement to Reuters. The decision reflects Novartis'  evolving research and development priorities .